chronic lymphocytic leukemia

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

chronic lymphocytic leukemia
Dec 7, 2024, 02:54 | Insight
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia
Jonathan Friedberg, Director of Wilmot Cancer Institute, shared a recent article by Petra Langerbeins on…
Dec 3, 2024, 09:45 | Blog
Live symposia by NCCN: Expert insights on Bladder Cancer and the latest updates on CLL
National Comprehensive Cancer Network shared a post on LinkedIn: "Join us for live symposia this…
Nov 23, 2024, 16:54 | Insight
MD Anderson Research Highlights
Featuring a novel treatment for chronic pain, targeted therapies for MDS, the role of microRNAs…
Sep 12, 2024, 21:16 | Blog
Jan Burger reports a 10-year analysis from the RESONATE-2 study at SOHO24 - Lymphoma Hub
Lymphoma Hub shared a post on X: ''Congress/SOHO24/POSTER. Jan Burger from MD Anderson Cancer Center…
Sep 11, 2024, 07:11 | Blog
Paula Boultbee: Join me in raising awareness and advocating for equitable treatment options worldwide
Paula Boultbee shared on LinkedIn: “Today, I’m honored to share a special message from Dr.…
Sep 4, 2024, 16:08 | Blog
National Cancer Institute of Kenya commemorates World CLL Day 2024
National Cancer Institute of Kenya shared a post on X: ''Today, we commemorate World CLL…
Sep 3, 2024, 18:39 | Blog
We are working towards a future for individuals like George, affected by CLL - The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared on X: "September 1st, the global chronic lymphocytic leukemia (CLL)…
Sep 2, 2024, 09:00 | Blog
The Max Foundation's CEO shares a powerful message of commitment honoring those living with CLL
The Max Foundation shared a post on LinkedIn: "Today, our CEO Pat Garcia-Gonzalez shares a…
Aug 28, 2024, 11:11 | Blog
MD Anderson Research Highlights
Featuring a combination treatment for gastric cancer, positive ADC results in colorectal cancer, and a…
Aug 24, 2024, 10:51 | Insight
Shahrin Ahmed: High health care utilization and poor survival rate in older adults with AML
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: “Older…
Aug 21, 2024, 04:45 | Blog
This year's theme for the World CLL Day is "Level Up" - CLL Society
CLL Society shared a post on X: "World CLL Day is two weeks away! On…
Aug 7, 2024, 12:11 | Insight
Delineating the Role of Mitochondrial Dysregulation in Richter’s Transformation
Chronic lymphocytic leukemia (CLL) is a mature B cell disease identified by the aberrant expression…
Aug 6, 2024, 20:54 | Blog
The Max Foundation and BeiGene partner for CLL treatment in LMICs
The Max Foundation shared a post by BeiGene on LinkedIn: "We're grateful for the opportunity…
Jul 22, 2024, 07:05 | Insight
Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial
Mazyar Shadman, Associate Professor of Medical Oncology at Fred Hutch Cancer Center, shared on X about…
Jul 8, 2024, 10:45 | Blog
Treatment of Chronic Lymphocytic Leukemia and Richter's transformation - VJHemOnc
VJHemOnc shared a post on X: “Do not miss out on our recent session from…
Jul 1, 2024, 19:24 | Insight
Léa Ikhlef: The use of extracellular vesicles as a communication tool by TAMS in CLL
Léa Ikhlef, Postdoctoral researcher at Léon Bérard Center, shared on LinkedIn: “I'm glad to share…
Jun 29, 2024, 16:57 | Insight
MD Anderson Research Highlights: EHA 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Jun 24, 2024, 02:19 | Insight
Nitin Jain: Pirtobrutinib Venetoclax and Obinutuzumab in First-Line treatment for CLL
Nitin Jain shared on X:                   . "Delighted…
Jun 10, 2024, 16:08 | Blog
It was great to catch up with Mazyar Shadman at ASCO24 - VJHemOnc
VJHemOnc shared a post on X: "It was great to catch up with Mazyar Shadman at…
Mar 19, 2024, 03:44 | Drugs
Nitin Jain: The U.S. FDA approves lisocabtagene maraleucel for adults with relapsed or refractory CLL or SLL
Nitin Jain, The Director of the Leukemia CAR-T Program at the MD Anderson Cancer Center,…
Mar 17, 2024, 15:46 | Blog
The first doses of a breakthrough treatment have been delivered to patients with chronic lymphocytic leukemia in Armenia and Nepal! - The Max Foundation
The Max Foundation made the following post on LinkedIn: "We have some amazing news today!…
All: 21 Posts: 1 - 100
Special Coverage